This effect could be mediated, at least in part, by inflammation induced by these agents (15), as well as by an upregulation of HIF1α that triggers a wide variety of resistance and survival mechanisms in cancer cells (9, 11, 16). This evidence concerns the gene HIF1A and cancer.